NASDAQ : MDXH
MDxHealth SA — Key statistics
Healthcare · Diagnostics & Research · Belgium
Last price 0.1812 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.29M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 15.23M |
| Enterprise Value | 101.87M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 95.42M |
| Shares Outstanding | 95.42M |
| Shares Change (YoY) | +13.74% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 7.44% |
| Owned by Institutions (%) | 48.95% |
| Float | 78.97M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | 0.13 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.15 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.66 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.83% |
| Return on Invested Capital (ROIC) | -16.91% |
| Return on Capital Employed (ROCE) | -22.66% |
| Weighted Average Cost of Capital (WACC) | -365,730.69% |
| Revenue Per Employee | $313,253 |
| Profits Per Employee | -$102,574 |
| Employee Count | 364 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 8.39 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.58M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -518,218.96 |
| 52-Week Price Change | -96.61% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 23.34 |
| Average Volume (20 Days) | 1,900,334 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.19M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 1.44% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.87 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 114.02M |
| Gross Profit | 71.67M |
| Operating Income | -21.46M |
| Pretax Income | -38.01M |
| Net Income | -37.34M |
| EBITDA | -14.93M |
| EBIT | -21.46M |
| Loss Per Share | -$0.74 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 19.21M |
| Total Debt | 105.85M |
| Net Cash | -86.64M |
| Net Cash Per Share | -$0.91 |
| Equity (Book Value) | -30.40M |
| Book Value Per Share | -0.59 |
| Working Capital | 5.63M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.30M |
| Capital Expenditures | -718,000 |
| Depreciation & Amortization | 6.53M |
| Net Borrowing | 16.72M |
| Free Cash Flow | -6.02M |
| FCF Per Share | -$0.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 62.86% |
| Operating Margin | -18.82% |
| Pretax Margin | -33.33% |
| Profit Margin | -32.74% |
| EBITDA Margin | -13.09% |
| EBIT Margin | -18.82% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.74% |
| Shareholder Yield | -13.74% |
| Earnings Yield | -464.59% |
| FCF Yield | -38.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $0.83 |
| Price Target Difference | 421.95% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 10.15% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.57 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |